Filing Details

Accession Number:
0001447348-13-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-23 09:59:44
Reporting Period:
2013-01-22
Filing Date:
2013-01-23
Accepted Time:
2013-01-23 09:59:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
835887 Progenics Pharmaceuticals Inc PGNX Pharmaceutical Preparations (2834) 133379479
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1331438 Robert Mark Baker 777 Old Saw Mill River Road
Tarrytown NY 10591
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-22 900 $2.82 158,914 No 4 P Direct
Common Stock Acquisiton 2013-01-22 315 $2.83 159,229 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.